- Home
- QSI vs HUMA Comparison
QSI vs HUMA Comparison
Compare QSI & HUMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QSI
- HUMA
- Stock Information
- Founded
- QSI 2013
- HUMA 2004
- Country
- QSI United States
- HUMA United States
- Employees
- QSI N/A
- HUMA N/A
- Industry
- QSI Biotechnology: Pharmaceutical Preparations
- HUMA Biotechnology: Pharmaceutical Preparations
- Sector
- QSI Health Care
- HUMA Health Care
- Exchange
- QSI Nasdaq
- HUMA Nasdaq
- Market Cap
- QSI 219.8M
- HUMA 367.6M
- IPO Year
- QSI N/A
- HUMA N/A
- Fundamental
- Price
- QSI $1.80
- HUMA $2.56
- Analyst Decision
- QSI Strong Buy
- HUMA Strong Buy
- Analyst Count
- QSI 3
- HUMA 7
- Target Price
- QSI $2.38
- HUMA $13.00
- AVG Volume (30 Days)
- QSI 9.0M
- HUMA 3.4M
- Earning Date
- QSI 08-06-2025
- HUMA 08-12-2025
- Dividend Yield
- QSI N/A
- HUMA N/A
- EPS Growth
- QSI N/A
- HUMA N/A
- EPS
- QSI N/A
- HUMA N/A
- Revenue
- QSI $3,443,000.00
- HUMA $517,000.00
- Revenue This Year
- QSI $77.57
- HUMA N/A
- Revenue Next Year
- QSI $251.34
- HUMA $896.45
- P/E Ratio
- QSI N/A
- HUMA N/A
- Revenue Growth
- QSI 167.94
- HUMA N/A
- 52 Week Low
- QSI $0.61
- HUMA $1.15
- 52 Week High
- QSI $5.77
- HUMA $9.79
- Technical
- Relative Strength Index (RSI)
- QSI 49.97
- HUMA 60.48
- Support Level
- QSI $1.87
- HUMA $2.13
- Resistance Level
- QSI $2.18
- HUMA $2.80
- Average True Range (ATR)
- QSI 0.14
- HUMA 0.17
- MACD
- QSI -0.02
- HUMA 0.01
- Stochastic Oscillator
- QSI 40.10
- HUMA 67.13
About QSI Quantum-Si Incorporated
Quantum-Si Inc is a life sciences company focused on the development and commercialization of proteomics research tools. The company has designed and developed a hardware, consumable, and software solution to provide a solution for protein detection and analysis. It has developed a proprietary universal single-molecule detection platform that enables Next-Generation Protein Sequencing (NGPS), the ability to sequence proteins.
About HUMA Humacyte Inc.
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Advanced Organ Systems, Advanced Tissue Constructs.